Eli Lilly finally published its disastrous EXPEDITION3 data, a costly lesson in rethinking Alzheimer's
Eli Lilly $LLY had hoped that EXPEDITION3 would prove to the world that amyloid beta was the cause of Alzheimer’s and that solanezumab could bend …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
